Is Ketamine the Next Frontier? This Cannabis Exec Thinks So - podcast episode cover

Is Ketamine the Next Frontier? This Cannabis Exec Thinks So

Jun 16, 202224 minSeason 1Ep. 162
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Ketamine has been shown to treat depression, PTSD, and anxiety. In recent years, clinics have been popping up in cities across America and Canada. Guest Matt Stang is co-founder and CEO of Delic Corp, the largest infrastructure of psychedelic wellness clinics in the U.S. Matt started his career as an intern at High Times and rose up the ranks to be its owner. Now he’s embarking on a new journey in psychedelics such as ketamine. Here’s why he think ketamine is so powerful and his predictions for the future of the psychedelics industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
For the best experience, listen in Metacast app for iOS or Android